临床医药实践
臨床醫藥實踐
림상의약실천
Proceeding of Clinical Medicine
2015年
10期
723-725
,共3页
李正中%江沛源%刘丹%谢芳林%陈林
李正中%江沛源%劉丹%謝芳林%陳林
리정중%강패원%류단%사방림%진림
小切口%辅助%肾镜碎石术%极度肥胖
小切口%輔助%腎鏡碎石術%極度肥胖
소절구%보조%신경쇄석술%겁도비반
small incision%assisted%renal lithotripsy%extreme obesity
目的:分析探讨辅助小切口肾镜碎石术在极度肥胖患者中的应用价值。方法:选择极度肥胖肾结石患者162例,按照数字表法随机分为对照组和治疗组,每组81例。对照组采用经皮肾镜取石术治疗,治疗组采用小切口辅助经皮肾镜碎石术治疗,对比分析两组患者结石清除率及并发症发生情况。结果:治疗组平均手术时间、平均术中出血量、并发症发生率等均明显少于对照组,治疗组手术耐受性以及结石清除率均明显高于对照组,差异有统计学意义(P <0.05)。结论:采用小切口辅助肾镜碎石术治疗极度肥胖肾结石,安全性高,治疗效果好,不良反应少。
目的:分析探討輔助小切口腎鏡碎石術在極度肥胖患者中的應用價值。方法:選擇極度肥胖腎結石患者162例,按照數字錶法隨機分為對照組和治療組,每組81例。對照組採用經皮腎鏡取石術治療,治療組採用小切口輔助經皮腎鏡碎石術治療,對比分析兩組患者結石清除率及併髮癥髮生情況。結果:治療組平均手術時間、平均術中齣血量、併髮癥髮生率等均明顯少于對照組,治療組手術耐受性以及結石清除率均明顯高于對照組,差異有統計學意義(P <0.05)。結論:採用小切口輔助腎鏡碎石術治療極度肥胖腎結石,安全性高,治療效果好,不良反應少。
목적:분석탐토보조소절구신경쇄석술재겁도비반환자중적응용개치。방법:선택겁도비반신결석환자162례,안조수자표법수궤분위대조조화치료조,매조81례。대조조채용경피신경취석술치료,치료조채용소절구보조경피신경쇄석술치료,대비분석량조환자결석청제솔급병발증발생정황。결과:치료조평균수술시간、평균술중출혈량、병발증발생솔등균명현소우대조조,치료조수술내수성이급결석청제솔균명현고우대조조,차이유통계학의의(P <0.05)。결론:채용소절구보조신경쇄석술치료겁도비반신결석,안전성고,치료효과호,불량반응소。
Objective:To analyze the application value of small incision renal lens lithotripsy in patients with extremely o-besity. Methods:All 162 cases of extremely obesity kidney stones were selected as the research object,and were randomly di-vided into control group and treatment group with 81 cases in each group,according to the digital table method. The control group was treated with percutaneous renal lens,the treatment group with small incision assisted percutaneous renal lithotripsy, the stone removal rate and complications of the two groups were compared and analyzed. Results:The mean operation time, mean intraoperative blood loss and complication rate in treatment group were significantly less than the control group,treatment group operation tolerance and the stone clearance rate were significantly higher than those in the control group,the difference is statistically significant(P < 0. 05). Conclusion:Small incision assisted renal lithotripsy lithotripsy for the treatment of extremely obesity kidney stones,high safety,good treatment,less adverse reactions.